Indeed, recent studies (8, 12, 14, 17) highlighted that convalescent COVID-19 patients with history of severe disease mounted more robust CD8+ memory T cell response to SARS-CoV-2 infection that could potentially lead to durable protection against re-exposure. The gene discussed is CD8A; the disease is COVID-19.